Instrumento Inactivo

Acciones BioMimetic Therapeutics, Inc.

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

BioMimetic Therapeutics, Inc. : Initiates Enrollment in Augment? Chronic Tendinopathy Clinical Trial	03/01/13
BioMimetic Therapeutics, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of BioMimetic Therapeutics, Inc.	20/11/12
BioMimetic Therapeutics, Inc. : BioMimetic Therapeutics Investor Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to Wright Medical Group	20/11/12
BioMimetic Therapeutics, Inc. : Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter into Agreement to Combine Businesses	19/11/12
BioMimetic Therapeutics, Inc. : Reports Third Quarter 2012 Financial Results	05/11/12

Sector

	Varia. 1 de ene.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+15,82 %	121 mil M
REGENERON PHARMACEUTICALS, INC.	+20,35 %	113 mil M
ARGENX SE	+17,47 %	26,02 mil M
BIONTECH SE	-25,31 %	19,39 mil M
GENMAB A/S	-19,51 %	15,91 mil M
BEIGENE, LTD.	-19,67 %	15,09 mil M
WUXI APPTEC CO., LTD.	-46,87 %	15,06 mil M
SAREPTA THERAPEUTICS, INC.	+62,55 %	14,93 mil M
NEUROCRINE BIOSCIENCES, INC.	+6,34 %	13,85 mil M